J Neuroimmunol. 2003 Oct;143(1-2):53-9
Yeo TW, Roxburgh R, Maranian M, Singlehurst S, Gray J, Hensiek A, Setakis E, Compston A, Sawcer S.
University of Cambridge Neurology Unit, Addenbrook's Hospital, Hills Road, CB2 2QQ, Cambridge, UK
Individual genotyping of the 10 most promising markers identified in our previously reported screen for linkage disequilibrium (LD) in multiple sclerosis identified a number of effects which confound the analysis and are of general importance in the interpretation of results obtained using microsatellite markers typed in pooled DNA.
In order to identify and characterise these effects, we individually genotyped 529 promising markers in 16 trio families.
We then devised adapting factors, which were designed to correct for these confounders.
This more extensive analysis of the previously published UK data set and the repeat analyses incorporating these adaptations led to the identification of two novel markers that may be associated with multiple sclerosis in this population, providing a close correlation between the results of pooled analysis and individual typing.